Evidence map›Paper›PMID 33602968›Full record

SynthesisScientific reports2021

A meta-analysis uncovers the first sequence variant conferring risk of Bell's palsy.

Astros Th Skuladottir, Gyda Bjornsdottir, Gudmar Thorleifsson, G Bragi Walters, Muhammad Sulaman Nawaz, Kristjan Helgi Swerford Moore, Pall I Olason, Thorgeir E Thorgeirsson, Brynja Sigurpalsdottir, Gardar Sveinbjornsson and 23 more

Open access · goldAbstract readMeta-Analysis
In one paragraph

Synthesis in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 3 pooled it
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 3 syntheses or guidelines pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors at 9 institutions in 2 countries.

Astros Th SkuladottirdeCODE Genetics/Amgen Inc, Reykjavik, Iceland. astros.skuladottir@decode.is.
Gyda BjornsdottirdeCODE Genetics/Amgen Inc, Reykjavik, Iceland.
Gudmar ThorleifssondeCODE Genetics/Amgen Inc, Reykjavik, Iceland.
G Bragi WaltersdeCODE Genetics/Amgen Inc, Reykjavik, Iceland.
Muhammad Sulaman NawazdeCODE Genetics/Amgen Inc, Reykjavik, Iceland.
Kristjan Helgi Swerford MooredeCODE Genetics/Amgen Inc, Reykjavik, Iceland.
Pall I OlasondeCODE Genetics/Amgen Inc, Reykjavik, Iceland.
Thorgeir E ThorgeirssondeCODE Genetics/Amgen Inc, Reykjavik, Iceland.
Brynja SigurpalsdottirdeCODE Genetics/Amgen Inc, Reykjavik, Iceland.
Gardar SveinbjornssondeCODE Genetics/Amgen Inc, Reykjavik, Iceland.
Hannes P EggertssondeCODE Genetics/Amgen Inc, Reykjavik, Iceland.
Sigurdur H MagnussondeCODE Genetics/Amgen Inc, Reykjavik, Iceland.
Asmundur OddssondeCODE Genetics/Amgen Inc, Reykjavik, Iceland.
Anna BjornsdottirLaeknasetrid Clinic, Reykjavik, Iceland.
Arnor VikingssonLandspitali - the National University Hospital of Iceland, Reykjavik, Iceland.
Olafur A SveinssonLandspitali - the National University Hospital of Iceland, Reykjavik, Iceland.
Maria G HrafnsdottirLandspitali - the National University Hospital of Iceland, Reykjavik, Iceland.
Gudrun R SigurdardottirLaeknasetrid Clinic, Reykjavik, Iceland.
Bjarni V HalldorssondeCODE Genetics/Amgen Inc, Reykjavik, Iceland.
Thomas Folkmann HansenKobenhavns Universitet, Kobenhavn, Denmark.
Helene PaarupOdense Universitetshospital, Odense, Denmark.
Christian ErikstrupAarhus Universitetshospital, Aarhus, Denmark.
Kaspar NielsenAalborg Universitetshospital, Aalborg, Denmark.
Mads KlokkerRigshospitalet, Kobenhavn, Denmark.
Mie Topholm BruunOdense Universitetshospital, Odense, Denmark.
Erik SorensenRigshospitalet, Kobenhavn, Denmark.
Karina BanasikKobenhavns Universitet, Kobenhavn, Denmark.
Kristoffer S BurgdorfRigshospitalet, Kobenhavn, Denmark.
Ole Birger PedersenNeastved Hospital, Neastved, Denmark.
Henrik UllumRigshospitalet, Kobenhavn, Denmark.
Ingileif JonsdottirdeCODE Genetics/Amgen Inc, Reykjavik, Iceland.
Hreinn StefanssondeCODE Genetics/Amgen Inc, Reykjavik, Iceland.
Kari StefanssondeCODE Genetics/Amgen Inc, Reykjavik, Iceland.
deCODE Genetics (Iceland) · ISRigshospitalet · DKNational University Hospital of Iceland · ISOdense University Hospital · DKUniversity of Copenhagen · DKUniversity of Iceland · ISAalborg University Hospital · DKAarhus University · DKNæstved Sygehus · DK

Funding

Genes for human chronic pain syndromes through whole genome sequencingR01DE022905 · NIDCR · DECODE GENETICS, EHF · PI STEFANSSON, KARI · 2012 to 2016
$2.6M
NIDCR NIH HHS R01 DE022905
6 · The paper itself

Abstract

Bell's palsy is the most common cause of unilateral facial paralysis and is defined as an idiopathic and acute inability to control movements of the facial muscles on the affected side. While the pathogenesis remains unknown, previous studies have implicated post-viral inflammation and resulting compression of the facial nerve. Reported heritability estimates of 4-14% suggest a genetic component in the etiology and an autosomal dominant inheritance has been proposed. Here, we report findings from a meta-analysis of genome-wide association studies uncovering the first unequivocal association with Bell's palsy (rs9357446-A; P = 6.79 × 10

Indexed as

AdultAgedBell PalsyFacial MusclesFacial NerveFacial ParalysisFemaleGenome-Wide Association StudyHumansInflammationMaleMiddle AgedMovementProspective StudiesRisk

Identifiers

PMID33602968
PMCPMC7893061
OpenAlexW3129315374

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.